A Pilot Clinical Study of Intravitreal Injection of Artesunate for Ocular Neovascularization

Author:

Li Cheng1,Feng Xiaoxiao1,Wen Xin2,Li Yujie1,Liu Bingqian1,Hu Jie1,Lu Lin1,Zhuo Yehong1,Fu Yue1,Qian Xiaobing1,Shao Wanwen1,Zheng Qishan1,Lin Leilei1,Yang Yao1,Zheng Haihua3,Lin Xiaofeng1,Gao Qianying1

Affiliation:

1. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.

2. Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

3. The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Therapeutic Applications of Artemisinin in Ophthalmic Diseases;2024

2. Examples for successful commercial production of plant-derived bioactive compounds;Scale-up and Chemical Process for Microbial Production of Plant-Derived Bioactive Compounds;2024

3. Artesunate mitigates choroidal neovascularization and scar formation;Experimental Eye Research;2023-11

4. Retinal safety and toxicity study of artesunate in vitro and in vivo;Advances in Ophthalmology Practice and Research;2023-05

5. Drug Repurposing Patent Applications January–March 2022;ASSAY and Drug Development Technologies;2022-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3